Share

New cost-effectiveness data may transform the prescribing for schizophrenia treatments around the world

Schizophrenia -- The Real Cost

Exploring the Cost Equation

Renacimiento II Room, Miguel Angel Hotel,
Madrid, Spain
27 April 2000, 11:30am local time

P R E S S B R I E F I N G

11.30 Welcome & Introduction Professor Siegfried Kasper (Chairman)

11.35 The Human Cost of Schizophrenia
Gary Hogman, National Schizophrenia Fellowship (UK)

11.45 Why Cost Matters
Professor Martin Knapp, London School of Economics, (UK)

11.55 Studying Real-Life Outcomes
Dr Koen Torfs

12.05 RODOS: Results
Professor Siegfried Kasper, University Hospital for Psychiatry, Vienna

12.25 Relapse Prevention -- The Long-Term Goal
Dr Richard Williams, Canada

12.45 Questions to the Panel

13.05 Chairman's Conclusions

13.10 Close: Buffet lunch will be served

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.